Seelos Therapeutics, Inc.
SEEL
Revenue
376.00k
▼-203.00k▼-35.06%
3 Months ChangeAssets
2.38M
▼-1.23M▼-34.08%
3 Months ChangeLiabilities
30.51M
▼-6.20M▼-16.89%
3 Months ChangeFree Cash Flow
-6.13M
▲164.00k▲2.61%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-24
Form 8-K
ID: 0001104659-24-111155
2024-10-15
Form 8-K
ID: 0001104659-24-108396
2024-10-07
Form 8-K
ID: 0001104659-24-106406
2024-09-26
Form 8-K
ID: 0001104659-24-103143
2024-09-25
Form 8-K
ID: 0001104659-24-102625
2024-09-24
Form 8-K
ID: 0001104659-24-102434
2024-09-03
Form 8-K
ID: 0001104659-24-096067
2024-08-14
Form 10-Q
ID: 0001410578-24-001435
2024-08-08
Form 8-K
ID: 0001140361-24-036392
2024-07-26
Form 8-K
ID: 0001104659-24-083012